Pink Sheet Podcast: Bluebird Leaves Europe, Lilly’s Olympic TV Ads, Most Favored Nation Rule Pulled

Citeline Podcasts - A podcast by Citeline

Try Bookbeat 60! days for free, click here

Try Bookbeat 60! days for free, click here

Enjoy a whole world of audiobooks and e-books, everything from new releases to the classics

 Sponsored

Categories:

Business

Pink Sheet reporters and editors discuss Bluebird Bio’s decision to pull is gene therapy business from Europe, Eli Lilly potentially pushing regulatory boundaries with its Olympic TV spots, and the CMS decision to scrap the Trump Administration’s most favored nation rule.

Visit the podcast's native language site